Oz Biosciences

Oz Biosciences, established in 2003, develops cutting-edge transfection and transduction reagents for in vitro and in vivo biomolecule delivery. Oz has achieved a strong position in the field of molecular delivery systems with their innovative systems of Magnetofection™, a transfection method based on magnetic nanoparticles, Lipofection, a lipid-based transfection technology using biochemical methods, and Polyfection, a polymer-based transfection technology. Oz’s range of reagents includes specialized tools for CRISPR, stem cell applications, cell-specific reagents, and much more. Oz also provides vectors for achieving high levels of transgene expression. With these tools, transfection and transduction efficiency and performance is greatly improved.